February 26, 2025 - 02:04

Auditoria.AI has successfully raised $38 million in a Series B funding round aimed at expanding its innovative agentic artificial intelligence solutions tailored for enterprise finance teams. This significant investment underscores the growing demand for advanced AI technologies in the financial sector, as companies seek to streamline operations and improve decision-making processes.
The funds will be utilized to further develop Auditoria.AI's platform, which leverages machine learning and natural language processing to automate various financial tasks. By enhancing its capabilities, Auditoria.AI aims to empower finance professionals, allowing them to focus on strategic initiatives rather than routine data management.
The investment round attracted notable participation from various investors, reflecting confidence in Auditoria.AI's vision and potential for growth. As the financial landscape continues to evolve, the integration of sophisticated AI tools is becoming increasingly essential for organizations striving to maintain a competitive edge and enhance operational efficiency.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...